♢ At the end of a title indicates that the FDA has not cleared prescription drugs, approved medical devices and/or biologics for the use described in this presentation. The prescription drugs, approved medical devices and/or biologics are being discussed for an off-label use.

Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Name
      Event Title
        Event Type
          Category-Classification
            Event Day

              097 Optimal Timing for Cessation of GLP-1 Agonist Before Elective Total Hip and Knee Arthroplasty

              Author:Shivan Chokshi  Nuanqiu Hou, MS  Marcus Ford, MD,FAAOS  John Crockarell, MD, FAAOS  James Guyton, MD,FAAOS  William Mihalko, MD,PhD,FAAOS  Christopher Holland, MD,MS  

              Event Title:(097-104) VIPER: Adult Reconstruction Knee I Papers  

              Event Type:Paper Presentations  

              Category-Classification:Adult Reconstruction Knee  

              Event Day:Monday, March 10